3184-36-9 Usage
Chemical structure
The compound consists of a tetrahydroisoquinoline core with a hydroxyphenylmethyl group and two hydroxy groups attached to it.
Form
It is in the form of a hydrochloride salt.
Potential applications
It has potential pharmaceutical applications due to its structural resemblance to neurotransmitters and its ability to interact with various receptors in the body.
Implications
The compound may have implications in the development of therapeutic drugs for various conditions, including neurological disorders.
Further research
Further research and studies may reveal its specific biological activities and potential medical uses.
Molecular weight
Approximately 373.85 g/mol (with hydrochloride salt)
Solubility
The compound is likely to be soluble in water due to the presence of hydroxyl groups, which can form hydrogen bonds with water molecules.
Stability
The compound may be sensitive to light, heat, and moisture, as it contains phenolic hydroxyl groups that can undergo oxidation and other degradation reactions.
Purity
The purity of the compound can be determined using techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry.
Synthesis
The compound can be synthesized through various chemical reactions, such as the condensation of a tetrahydroisoquinoline with a suitable phenol derivative.
Biological activity
The compound's biological activity is not yet fully understood, but its structural similarity to neurotransmitters suggests that it may have the potential to modulate neurotransmission and receptor activity in the body.
Safety
As with any chemical compound, appropriate safety precautions should be taken when handling and studying this compound, including the use of personal protective equipment (PPE) and proper disposal methods.
Regulatory status
The regulatory status of this compound may vary depending on the country and its intended use (e.g., research, pharmaceutical development, etc.). It is essential to consult relevant guidelines and regulations before conducting research or development with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 3184-36-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,8 and 4 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3184-36:
(6*3)+(5*1)+(4*8)+(3*4)+(2*3)+(1*6)=79
79 % 10 = 9
So 3184-36-9 is a valid CAS Registry Number.
InChI:InChI=1/C16H17NO4.ClH/c18-13-2-1-9(6-14(13)19)5-12-11-8-16(21)15(20)7-10(11)3-4-17-12;/h1-2,6-8,12,17-21H,3-5H2;1H
3184-36-9Relevant articles and documents
Biosynthesis. Part 24. Speculative Incorporation Experiments with 1-Benzylisoquinolines and a Logical Approach via C6-C2 and C6-C3 Precursors to the Biosynthesis of Hasubanonine and Protostephanine
Battersby, Alan R.,Jones, Raymond C. F.,Kazlauskas, Rymantas,Thornber, Craig W.,Ruchirawat, Somsak,Staunton, James
, p. 2016 - 2029 (2007/10/02)
Many possible 1-benzyltetrahydroisoquinolines have been examined as possible advanced precursors of the alkaloids hasubanonine (1) and protostephanine (2) in Stephania japonica plants, but none was incorporated significantly.Administration of various precursor molecules having only one aromatic ring, such as tyrosine, has demonstrated that both alkaloids are derived from two different C6-C2 biogenetic units.The subsequent failure of further 1-benzyltetrahydroisoquinolines and bisphenethylamines to be incorporated suggested the intermediacy of either (a) modified 1-benzylisoquinolines or (b) trioxygenated C6-C2 building blocks.Precursors designed to examine the first possibility, such as 1-benzyl-3,4-dihydroisoquinolines or 1-benzyl-1-carboxytetrahydroisoquinolines, were not incorporated into (1) and (2) whereas two 3',4',5'-trioxygenated 2-phenylethylamines were incorporated.These findings allow further delineation of the requirements for later precursors of the alkaloids (1) and (2).
